Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shibamoto

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|October 1, 1995
Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II studyB Jeremic, D Grujicic, V Antunovic, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1991
Variations of the hypoxic fraction in the SCC VII tumors after single dose and during fractionated radiation therapy: assessment without anesthesia or physical restraint of miceY Kitakabu, Y Shibamoto, K Sasai, et al.
Japanese Journal of Cancer Research : Gann|May 11, 2000
A novel class of antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiationY Shibamoto, L Zhou, H Hatta, et al.
Journal of Radiation Research|December 1, 1985
The effect of N6-butyrylcordycepin on potentially lethal damage repair in vivoY Shibamoto, C Komuro, M Takahashi, et al.
Journal of Chemotherapy (Florence, Italy)|November 8, 2002
Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugsY Shibamoto, Y Mimasu, Y Tachi, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1986
Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sitesY Shibamoto, Y Yukawa, K Tsutsui, et al.
Nihon Gan Chiryo Gakkai Shi|December 20, 1989
[Results of radiation therapy for medulloblastoma]Y Shibamoto, M Abe, K Tsutsui, et al.
Cancer|July 18, 2000
Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosisY Aizawa, Y Shibamoto, I Takagi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation dosesN Oya, Y Shibamoto, K Sasai, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|November 25, 1986
[Reoxygenation after a single dose of 15 Gy in the EMT6/KU sarcoma]Y Shibamoto, Y Nishimura, T Nishidai, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|October 1, 1995
Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II studyB Jeremic, D Grujicic, V Antunovic, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1991
Variations of the hypoxic fraction in the SCC VII tumors after single dose and during fractionated radiation therapy: assessment without anesthesia or physical restraint of miceY Kitakabu, Y Shibamoto, K Sasai, et al.
Japanese Journal of Cancer Research : Gann|May 11, 2000
A novel class of antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiationY Shibamoto, L Zhou, H Hatta, et al.
Journal of Radiation Research|December 1, 1985
The effect of N6-butyrylcordycepin on potentially lethal damage repair in vivoY Shibamoto, C Komuro, M Takahashi, et al.
Journal of Chemotherapy (Florence, Italy)|November 8, 2002
Comparison of 5-fluorouracil and 5-fluoro-2'-deoxyuridine as an effector in radiation-activated prodrugsY Shibamoto, Y Mimasu, Y Tachi, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1986
Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sitesY Shibamoto, Y Yukawa, K Tsutsui, et al.
Nihon Gan Chiryo Gakkai Shi|December 20, 1989
[Results of radiation therapy for medulloblastoma]Y Shibamoto, M Abe, K Tsutsui, et al.
Cancer|July 18, 2000
Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosisY Aizawa, Y Shibamoto, I Takagi, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1993
In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation dosesN Oya, Y Shibamoto, K Sasai, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|November 25, 1986
[Reoxygenation after a single dose of 15 Gy in the EMT6/KU sarcoma]Y Shibamoto, Y Nishimura, T Nishidai, et al.
Pageof 20